- Home
- PYPD vs STRR Comparison
PYPD vs STRR Comparison
Compare PYPD & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- STRR
- Stock Information
- Founded
- PYPD 2008
- STRR 1985
- Country
- PYPD Israel
- STRR United States
- Employees
- PYPD N/A
- STRR N/A
- Industry
- PYPD Medical/Dental Instruments
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PYPD Health Care
- STRR Health Care
- Exchange
- PYPD Nasdaq
- STRR Nasdaq
- Market Cap
- PYPD 36.0M
- STRR 6.3M
- IPO Year
- PYPD 2020
- STRR N/A
- Fundamental
- Price
- PYPD $3.38
- STRR $1.96
- Analyst Decision
- PYPD Strong Buy
- STRR Strong Buy
- Analyst Count
- PYPD 5
- STRR 1
- Target Price
- PYPD $11.40
- STRR $5.00
- AVG Volume (30 Days)
- PYPD 215.1K
- STRR 9.6K
- Earning Date
- PYPD 08-13-2025
- STRR 08-12-2025
- Dividend Yield
- PYPD N/A
- STRR N/A
- EPS Growth
- PYPD N/A
- STRR N/A
- EPS
- PYPD N/A
- STRR N/A
- Revenue
- PYPD N/A
- STRR $57,165,000.00
- Revenue This Year
- PYPD N/A
- STRR $33.64
- Revenue Next Year
- PYPD N/A
- STRR $22.87
- P/E Ratio
- PYPD N/A
- STRR N/A
- Revenue Growth
- PYPD N/A
- STRR 34.33
- 52 Week Low
- PYPD $2.30
- STRR $1.72
- 52 Week High
- PYPD $4.42
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- PYPD 51.00
- STRR 43.68
- Support Level
- PYPD $3.34
- STRR $1.94
- Resistance Level
- PYPD $3.53
- STRR $2.00
- Average True Range (ATR)
- PYPD 0.15
- STRR 0.05
- MACD
- PYPD -0.04
- STRR 0.00
- Stochastic Oscillator
- PYPD 14.68
- STRR 16.67
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.